Leveraging ethnic group incidence variation to investigate genetic susceptibility to glioma: A novel candidate SNP approach

Frontiers in Genetics

Volumn 3, Issue OCT, 2012, Pages

  Jacobs, Daniel I ^a   Walsh, Kyle M ^b   Wrensch, Margaret ^b   Wiencke, John ^b   Jenkins, Robert ^c   Houlston, Richard S ^d   Bondy, Melissa ^e   Simon, Matthias ^f   Sanson, Marc ^g,h   Gousias, Konstantinos ^f   Schramm, Johannes ^f   Labussière, Marianne ^g   Di Stefano, Anna Luisa ^g   Wichmann, H Erich ^i,j,k   Müller Nurasyid, Martina ^i,j,k   Schreiber, Stefan ^l,m   Franke, Andre ^m   Moebus, Susanne ⁿ   Eisele, Lewin ⁿ   Dewan, Andrew T ^a   Dubrow, Robert ^a   more..

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Mayo Clinic   (United States)

^d INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY HOSPITAL BONN   (Germany)

^g INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE   (France)

^h PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

ⁱ INSTITUTE OF EPIDEMIOLOGY   (Germany)

^j UNIVERSITY OF MUNICH   (Germany)

^k LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^l UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^m UNIVERSITY OF KIEL   (Germany)

ⁿ UNIVERSITY HOSPITAL ESSEN   (Germany)

more..

Author keywords

Admixture; Ancestry informative markers; Brain cancer; Candidate SNP association study; Ethnicity; Glioma; Race

Indexed keywords

EID: 84876151205     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2012.00203     Document Type: Article

References (36)

1. Altshuler, D. M., Gibbs, R. A., Peltonen, L., Dermitzakis, E., Schaffner, S. F., Yu, F., et al. (2010). Integrating common and rare genetic variation in diverse human populations. Nature 467, 52-58.
2. Barrett, J. C., Fry, B., Maller, J., and Daly, M. J. (2005). Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263-265.
3. Blankenberg, D., Kuster, G. V., Coraor, N., Ananda, G., Lazarus, R., Man-gan, M., et al. (2001). Galaxy: a web-based genome analysis tool for experimentalists. Curr. Protoc. Mol. Biol. 89, 1-21.
4. Bondy, M. L., Scheurer, M. E., Malmer, B., Barnholtz-Sloan, J. S., Davis, E G., Il'Yasova, D., et al. (2008). Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer 113, 1953-1968.
5. Cardis, E., Deltour, I., Vrijheid, M., Combalot, E., Moissonnier, M., Tardy, H.,et al. (2010). Brain tumour risk in relation to mobile telephone use: results of the INTERPHONE international case-control study. Int. J. Epidemiol. 39, 675-694.
6. Chen, P., Aldape, K., Wiencke, J. K., Kelsey, K. T., Miike, R., Davis, R. L., et al. (2001). Ethnicity delineates different genetic pathways in malignant glioma. Cancer Res. 61,3949-3954.
7. Cochran, W. G. (1954). The combination of estimates from different experiments. Biometrics 10, 101-129.
8. Darefsky, A. S., and Dubrow, R. (2009). International variation in the incidence of adult primary malignant neoplasms of the brain and central nervous system. Cancer Causes Control 20, 1593-1604.
9. Das, A., Tan, W.-L., Teo, J., and Smith, D. R. (2002). Glioblastoma multi-forme in an Asian population: evidence for a distinct genetic pathway. J. Neurooncol. 60, 117-125.
10. Davis, F., Il'Yasova, D., Rankin, K., McCarthy, B., and Bigner, D. D. (2011). Medical diagnostic radiation exposures and risk of gliomas. Radiat. Res. 175,790-796.
11. Dubrow, R., and Darefsky, A. S. (2011). Demographic variation in incidence of adult glioma by subtype, United States, 1992-2007. BMC Cancer 11, 325-325. doi:10.1186/1471-2407-11-325
12. Efird, J., Friedman, G., Sidney, S., Klatsky, A., Habel, L., Udaltsova, N., et al. (2004). The risk for malignant primary adult-onset glioma in a large, multiethnic, managed-care cohort: cigarette smoking and other lifestyle behaviors. J. Neurooncol. 68, 57-69.
13. Hercberg, S., Galan, P., Preziosi, P., Bertrais, S., Mennen, L., Malvy, D., et al. (2004). The SU.VI.MAX study: a randomized, placebo-controlled trial of the health effects of antiox-idant vitamins and minerals. Arch. Intern. Med. 164, 2335-2342.
14. Holle, R., Happich, M., Löwel, H., and Wichmann, H. E. (2005). KORA -a research platform for population based health research. Gesund-heitswesen 67, 19-25.
15. Hunter, D. J., Kraft, P., Jacobs, K. B., Cox, D. G., Yeager, M., Hankinson, S. E., et al. (2007). A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat. Genet. 39, 870-874.
16. Kohler, B. A., Ward, E., McCarthy, B. J., Schymura, M. J., Ries, L. G., Eheman, C., et al. (2011). Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J. Natl. Cancer Inst. 103, 1-23.
17. Krawczak, M., Nikolaus, S., Von Eber-stein, H., Croucher, P. J. P., El Mokhtari, N. E., and Schreiber, S. (2006). PopGen: population-based recruitment of patients and controls for the analysis of complex genotype-phenotype relationships. PublicHealth Genomics 9, 55-61.
18. Lachance, D. H., Yang, P., Johnson, D. R., Decker, P. A., Kollmeyer, T. M., McCoy, L. S., et al. (2011). Associations of high-grade glioma with glioma risk alleles and histories of allergy and smoking. Am. J. Epidemiol. 174,574-581.
19. Levy, D., Ehret, G. B., Rice, K., Verwoert, G. C., Launer, L. J., Dehghan, A., et al. (2009). Genome-wide association study of blood pressure and hypertension. Nat. Genet. 41, 677-687.
20. Mandelzweig, L., Novikov, I., and Sadet-zki, S. (2009). Smoking and risk of glioma: a meta-analysis. Cancer Causes Control 20, 1927-1938.
21. McLendon, R., Friedman, A., Bigner, D., and Meir, E. G. V. (2008). Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455, 1061-1068.
22. Mochizuki, S., Iwadate, Y., Namba, H., Yoshida, Y., Yamaura, A., Sakiyama, S., et al. (1999). Homozygous deletion of the p16/MTS-1/CDKN2 gene in malignant gliomas is infrequent among Japanese patients. Int. J. Oncol. 15, 983-992.
23. Ostrom, Q. T., and Barnholtz-Sloan, J. S. (2011). Current state of our knowledge on brain tumor epidemiology. Curr. Neurol. Neurosci. Rep. 11,329-335.
24. Patterson, N., Hattangadi, N., Lane, B., Lohmueller, K. E., Hafler, D. A., Oksenberg, J. R., et al. (2004). Methods for high-density admixture mapping of disease genes. Am. J. Hum. Genet. 74, 979-1000.
25. Power, C., and Elliott, J. (2006). Cohort profile: 1958 British birth cohort (National Child Development Study). Int. J. Epidemiol. 35, 34-41.
26. Price, A. L., Patterson, N. J., Plenge, R. M., Weinblatt, M. E., Shadick, N. A., and Reich, D. (2006). Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38, 904-909.
27. Sanson, M., Hosking, E J., Shete, S., Zelenika, D., Dobbins, S. E., Ma, Y., et al. (2011). Chromosome 7p11.2 (EGFR) variation influences glioma risk. Hum. Mol. Genet. 20, 2897-2904.
28. Schmermund, A., Möhlenkamp, S., Stang, A., Grönemeyer, D., Seibel, R., Hirche, H., et al. (2002). Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocar-dial infarction and cardiac death in healthy middle-aged subjects: rationale and design of the Heinz Nixdorf RECALL Study. Am. Heart J. 144, 212-218.
29. Schoemaker, M. J., Robertson, L., Wigertz, A., Jones, M. E., Hosking, E J., Feychting, M., et al. (2010). Interaction between 5 genetic variants and allergy in glioma risk. Am. J. Epidemiol. 171, 1165-1173.
30. Shete, S., Hosking, F. J., Robertson, L. B., Dobbins, S. E., Sanson, M., Malmer, B., et al. (2009). Genome-wide association study identifies five susceptibility loci for glioma. Nat. Genet. 41, 899-904.
31. Smith, M. W., and O'Brien, S. J. (2005). Mapping by admixture linkage disequilibrium: advances, limitations and guidelines. Nat. Rev. Genet. 6, 623-632.
32. Wichmann, H. E., Gieger, C., and Illig, T. (2005). KORA-Gen: resource for population genetics, controls and a broad spectrum of disease phenotypes. Gesundheitswesen 67, 26-30.
33. Wiencke, J. K., Aldape, K., McMillan, A., Wiemels, J., Moghadassi, M., Miike, R., et al. (2005). Molecular features of adult glioma associated with patient race/ethnicity, age, and a polymorphism in O6-methylguanine-DNA-methyltransferase. Cancer Epidemiol. Biomarkers Prev. 14, 1774-1783.
34. Wrensch, M., Jenkins, R. B., Chang, J. S., Yeh, R.-F., Xiao, Y., Decker, P. A., et al. (2009). Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat. Genet. 41, 905-908.
35. Wrensch, M., Yost, M., Miike, R., Lee, G., and Touchstone, J. (1999). Adult glioma in relation to residential power frequency electromagnetic field exposures in the San Francisco Bay area. Epidemiology 10, 523-527.
36. Zhu, X., Young, J. H., Fox, E., Keating, B. J., Franceschini, N., Kang, S., et al. (2011). Combined admixture mapping and association analysis identifies a novel blood pressure genetic locus on 5p13: contributions from the CARe consortium. Hum. Mol. Genet. 20,2285-2295.